Cyclosporine Dosing for 22 kg Child with Atopic Dermatitis
For a 22 kg child with atopic dermatitis, start cyclosporine at 2.5-5 mg/kg/day (55-110 mg/day total), divided into two daily doses, with the higher end (5 mg/kg/day = 110 mg/day) reserved for severe disease requiring rapid control. 1
Dosing Strategy
The most recent AAD pediatric guidelines 1 specify:
- Starting dose range: 2.5-5 mg/kg/day
- For your 22 kg patient: 55-110 mg daily
- Divide into twice-daily dosing (e.g., 27.5 mg BID at lower dose or 55 mg BID at higher dose)
- Start at the higher end (5 mg/kg/day) when rapid control is needed for severe disease
- Start at the lower end (2.5 mg/kg/day) when time is less critical, then increase if inadequate response after 1 month
The British guidelines 2 corroborate this approach, emphasizing that doses below 2.5 mg/kg/day are inadequate for initial control, though they may work for maintenance.
Titration and Duration
Initial phase:
- Once control is achieved, decrease gradually by 0.5-1 mg/kg steps to find the lowest effective dose 1, 2
- If starting at 2.5 mg/kg/day shows insufficient improvement after 1 month, increase the dose 2
- Maximum dose should not exceed 5 mg/kg/day (110 mg/day for this child)
Treatment duration:
- Generally limited to 1 year 1
- Short courses of 6 months are preferred when possible 2
- Research shows longer courses (mean 10.9 months) may reduce relapse risk compared to shorter courses 3
- The British guidelines 2 confirm cyclosporine is effective and well-tolerated in children aged 2 years and older for courses of 6 weeks to 1 year
Administration Details
- Take on empty stomach or before meals 2
- Available as 25 mg, 50 mg, 100 mg capsules or 100 mg/mL liquid 2
- For 22 kg child at 2.5 mg/kg/day: Use 25 mg capsule BID (total 50 mg/day) or 27.5 mg BID using liquid
- For 22 kg child at 5 mg/kg/day: Use 50 mg capsule BID (total 100 mg/day) or 55 mg BID using liquid
Critical Monitoring Requirements
First 2 months:
- Serum creatinine and blood pressure every 2 weeks 2
- More frequent if any elevation occurs
After 2 months:
- Monthly monitoring of creatinine and blood pressure 2
- Can extend to every 2-3 months once stable after 4 months 2
Action thresholds:
- If creatinine rises >30% above baseline: repeat within 2 weeks; if sustained, reduce dose 2
- Discontinue if adequate response not achieved within 6 weeks at maximum dose 2
Evidence Quality
The pediatric evidence is robust 2: trials demonstrate cyclosporine is effective and well-tolerated in children aged 2+ years. Research studies 4, 5 show that even low-dose therapy (2.5 mg/kg/day) achieves clinical improvement in 70-80% of children with severe AD, with significant SCORAD reductions. One study 4 found 4 of 7 responders achieved control at just 2.5 mg/kg/day.
Important Caveats
- Modified vs non-modified formulations are NOT interchangeable - verify which formulation is dispensed as bioavailability differs 2
- Cyclosporine is off-label for pediatric AD (FDA-approved only for ages ≥16 years) but widely used with strong guideline support 1, 2
- Avoid concurrent phototherapy - increases skin cancer risk 2
- Continue optimized topical therapy alongside cyclosporine to reduce required dose and maintain clearance during taper 2
- Most patients (96%) eventually discontinue due to limited efficacy or side effects, often transitioning to advanced therapies 6